Table 5 Liver stiffness measurement changing according to treatment regimen
| Â | Baseline versus week24 | Baseline versus week48 | ||||||
|---|---|---|---|---|---|---|---|---|
Overall (n = 84) | ETV (n = 44) | TDF (n = 40) | p value | Overall (n = 84) | ETV (n = 44) | TDF (n = 40) | p value | |
LSM decrease | ||||||||
kPa value* | 1.23 (0.3–2.8) | 1.19 (0.2–2.4) | 1.27 (0.2–2.8) | 0.098 | 1.88 (0.1–4.8) | 1.84 (0.1–3.5) | 1.92 (0.1–4.8) | 0.174 |
kPa %* | 13.3 (3.1–22.8) | 13.1 (2.1–22.8) | 13.4 (2.3–21.7) |  | 20.3 (2.1–37.8) | 19.9 (2.7–36.5) | 20.8 (2.1–37.8) |  |
m/s value* | 0.22 (0.03–0.31) | 0.21 (0.02–0.30) | 0.23 (0.02–0.31) | 0.734 | 0.35 (0.03–0.44) | 0.33 (0.03–0.39) | 0.37 (0.04–0.44) | 0.234 |
m/s %* | 12.3 (1.9–21.9) | 11.7 (1.9–20.6) | 12.9 (2.6–21.9) |  | 19.6 (1.4–38.6) | 18.4 (1.4–35.3) | 20.7 (1.5–38.6) |  |
LSM decrease | ||||||||
 > 10%, n (%) | 47 (55.9) | 25 (56.8) | 22 (55.0) | 0.802 | 50 (59.5) | 27 (61.4) | 23 (57.5) | 0.588 |
 > 20%, n (%) | 9 (10.7) | 5 (11.4) | 4 (10.0) | 0.659 | 22 (26.2) | 12 (27.3) | 10 (25.0) | 0.915 |